Showing results (961-970 of 981) with videos related to

Sort By:
Pageof 99
ACS Nano|April 15, 2016
Multilayer Transfer Printing for Pixelated, Multicolor Quantum Dot Light-Emitting DiodesBong Hoon Kim, Sooji Nam, Nuri Oh, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 20, 2021
Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumabNarikazu Boku, Taroh Satoh, Min-Hee Ryu, et al.
Journal of Gastric Cancer|July 26, 2014
Clinical practice guidelines for gastric cancer in Korea: an evidence-based approachJun Haeng Lee, Jae G Kim, Hye-Kyung Jung, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|December 22, 2019
A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update dataLi-Tzong Chen, Taroh Satoh, Min-Hee Ryu, et al.
Nephron|August 21, 2002
Insomnia in diabetic hemodialysis patients. Prevalence and risk factors by a multicenter studySang-Youb Han, Jong-Woo Yoon, Sang-Kyung Jo, et al.
The Korean Journal of Gastroenterology = Taehan Sohwagi Hakhoe Chi|February 25, 2014
[Synopsis on clinical practice guideline of gastric cancer in Korea: an evidence-based approach]Jun Haeng Lee, Jae G Kim, Hye Kyung Jung, et al.
Lancet (London, England)|October 11, 2017
Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trialYoon-Koo Kang, Narikazu Boku, Taroh Satoh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 23, 2016
Development and Validation of a Six-Gene Recurrence Risk Score Assay for Gastric CancerKeun-Wook Lee, Sung Sook Lee, Jun-Eul Hwang, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|May 16, 2019
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancerTaroh Satoh, Yoon-Koo Kang, Yee Chao, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 4, 2021
Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 studyYoon-Koo Kang, Satoshi Morita, Taroh Satoh, et al.
Pageof 99